Patients on Buprenorphine Formulations Undergoing Surgery

Katelynn Champagne, Preshita Date, Juan Pablo Forero, Joshua Arany, Karina Gritsenko

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of Review: To review the pharmacology of buprenorphine, the evolution of buprenorphine dosing recommendations, and the current literature regarding its recommendations for the perioperative period. Recent Findings: There is a consensus that for all surgeries, buprenorphine should be continued throughout the perioperative period. If the surgery is a minimal to mild pain surgery, no dose adjustment is needed. There is no clear consensus regarding moderate to severe pain. With all surgeries, multimodal analgesia should be utilized, with regional anesthesia when possible. Summary: Patients taking buprenorphine should continue their buprenorphine perioperatively; whether to decrease or maintain dosing is up for debate. Multimodal analgesia should also be used throughout the perioperative period, and communication between the patient and all provider teams is of the utmost importance to provide adequate analgesia during the perioperative period, as well as to arrange safe analgesia upon discharge.

Original languageEnglish (US)
Pages (from-to)459-468
Number of pages10
JournalCurrent pain and headache reports
Volume26
Issue number6
DOIs
StatePublished - Jun 2022

Keywords

  • Buprenorphine
  • Buprenorphine pharmacology
  • Multimodal analgesia
  • Perioperative buprenorphine
  • Pre-operative buprenorphine, Post-operative buprenorphine

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Patients on Buprenorphine Formulations Undergoing Surgery'. Together they form a unique fingerprint.

Cite this